Skip to main content
    J

    Jaguar Animal Health Inc (JAGX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.39
    -0.03 (-7.74%)

    Market Cap: $5.59M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Jaguar Animal Health Inc (JAGX) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Jaguar Animal Health are Processa Pharmaceuticals (PCSA), Soligenix (SNGX) and VistaGen Therapeutics (VTGN). By market cap, Jaguar Animal Health ranks 4th of the 13 companies on this page; VistaGen Therapeutics (VTGN) is the largest at $8.01M.

    Peer Comparison

    JAGX's ROIC of -98.4% is above the peer median of -515.4%, and its revenue growth of -58.9% is below the median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Jaguar Animal Health (JAGX)$5.59MN/AN/A-130.8%-98.4%-58.9%0.00%
    Processa Pharmaceuticals Inc (PCSA)$5.20MN/AN/A0.0%N/A0.0%0.00%
    Soligenix Inc. (SNGX)$7.50MN/AN/A0.0%N/A-100.0%0.00%
    VistaGen Therapeutics Inc (VTGN)$8.01MN/A3.4x0.0%N/A-46.5%0.00%
    Jupiter Neurosciences, Inc. Common Stock (JUNS)$2.32MN/A21.0x0.0%1154.5%0.0%0.00%
    Skye Bioscience, Inc. Common Stock (SKYE)$4.83MN/AN/A0.0%-3685.3%0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Galmed Pharmaceuticals Ltd (GLMD)$4.95MN/AN/A0.0%N/A0.0%N/A
    SeaStar Medical Holding Corporation (ICU)$4.46MN/A1.7x0.0%N/A82.0%0.00%
    Traws Pharma Inc (TRAW)$3.86MN/AN/A0.0%N/A-100.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Kiora Pharmaceuticals Inc (KPRX)$5.44MN/A6.2x0.0%N/A0.0%0.00%
    Tempest Therapeutics Inc (TPST)$7.64MN/AN/A0.0%-783.6%0.0%0.00%
    Peer median$4.89MN/A4.8x0.0%-515.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Jaguar Animal Health, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Processa Pharmaceuticals Inc (PCSA)
    Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients...
    PCSA competitors
    Soligenix Inc. (SNGX)
    Soligenix, Inc., an advanced stage biopharmaceutical company, focuses on developing and marketing products to treat rare diseases in the United States.
    SNGX competitors
    VistaGen Therapeutics Inc (VTGN)
    VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing and commercializing several drugs with the potential...
    VTGN competitors
    Jupiter Neurosciences, Inc. Common Stock (JUNS)
    Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company...
    JUNS competitors
    Skye Bioscience, Inc. Common Stock (SKYE)
    Skye Bioscience, Inc., a clinical stage biopharmaceutical company, discovers, develops...
    SKYE competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Galmed Pharmaceuticals Ltd (GLMD)
    Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapies for the treatment of liver diseases.
    SeaStar Medical Holding Corporation (ICU)
    SeaStar Medical Holding Corporation (ICU) is a forward-looking biotechnology company dedicated to innovating treatment solutions for chronic kidney disease via...
    ICU competitors
    Traws Pharma Inc (TRAW)
    Traws Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer in the United States.
    TRAW competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Kiora Pharmaceuticals Inc (KPRX)
    Kiora Pharmaceuticals Inc. is a clinical-stage biotechnology firm focused on developing innovative therapies for ocular diseases and neurodegenerative...
    KPRX competitors
    Tempest Therapeutics Inc (TPST)
    Tempest Therapeutics Inc., a clinical-stage oncology company, is dedicated to the development of small molecules that combine targeted and immune-mediated...
    TPST competitors

    Frequently Asked Questions About JAGX

    Who are Jaguar Animal Health's main competitors?

    The companies most similar to Jaguar Animal Health include Processa Pharmaceuticals (PCSA), Soligenix (SNGX), VistaGen Therapeutics (VTGN), Jupiter Neurosciences, Inc. Common Stock (JUNS) and Skye Bioscience, Inc. Common Stock (SKYE), listed from the closest match.

    Who is Jaguar Animal Health's biggest competitor?

    VistaGen Therapeutics (VTGN) is the largest of the similar companies at $8.01M; Processa Pharmaceuticals (PCSA) is the closest match by business profile, size, sector and industry.

    How does JAGX stock compare with its competitors?

    JAGX's net margin is -130.8% against a peer median of 0.0%.

    Which of Jaguar Animal Health's competitors pays a higher dividend?

    Jaguar Animal Health pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Jaguar Animal Health bigger than its competitors?

    No. Jaguar Animal Health is 4th by market cap among the 13 companies on this page; the largest is VistaGen Therapeutics (VTGN) at $8.01M.